Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV)
- 9 May 2005
- Vol. 23 (25) , 3341-3348
- https://doi.org/10.1016/j.vaccine.2005.01.091
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational ChangesJournal of Virology, 2004
- Dissection of Human Immunodeficiency Virus Type 1 Entry with Neutralizing Antibodies to gp41 Fusion IntermediatesJournal of Virology, 2002
- Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41Journal of Virology, 2001
- Multiepitope Vaccines Intensively Increased Levels of Antibodies Recognizing Three Neutralizing Epitopes on Human Immunodeficiency Virus-1 Envelope ProteinScandinavian Journal of Immunology, 2000
- Porcine Endogenous Retroviruses Inhibit Human Immune Cell Function: Risk for Xenotransplantation?Virology, 2000
- Vaccine developmentsNature Medicine, 1998
- Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in catsVaccine, 1991
- Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope ProteinsScience, 1985
- The occurrence of feline leukaemia virus neutralizing antibodies in catsInternational Journal of Cancer, 1978
- The frequency of occurrence of feline leukaemia virus subgroups in catsInternational Journal of Cancer, 1978